noncommunicable disease

Novartis Access and Government of Pakistan Sign Memorandum of Understanding

Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation.
Press Release

May 12, 2017 /3BL Media/ -- We are pleased to announce that Novartis and the Ministry of National Health Services, Regulation and Coordination of the Islamic Republic of Pakistan have signed a Memorandum of Understanding to implement Novartis Access in Pakistan. Novartis Access medicines will be made available to the poorest population through hospitals under the Prime Minister’s National Health Insurance Program.

Novartis Launches ‘Novartis Access’, a Portfolio of Affordable Medicines to Treat Chronic Diseases in Lower-income Countries

First-of-its-kind portfolio approach in healthcare industry, aiming to increase availability and affordability of 15 medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer
Summary: 
  • First-of-its-kind portfolio approach in healthcare industry, aiming to increase availability and affordability of 15 medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer
  • Novartis portfolio to be offered to governments and non-governmental organizations in low- and low-middle-income countries for USD 1 per treatment, per month
  • Some 28 million people die from chronic diseases in low- and middle-income countries each year, representing 75% of such deaths globally1
Press Release
  • First-of-its-kind portfolio approach in healthcare industry, aiming to increase availability and affordability of 15 medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer
  • Novartis portfolio to be offered to governments and non-governmental organizations in low- and low-middle-income countries for USD 1 per treatment, per month
  • Some 28 million people die from chronic diseases in low- and middle-income countries each year, representing 75% of such deaths globally1

A New Health Care Model for Mexico

Blog

Today's guest blog comes from Dr. Héctor Gallardo-Rincon, director of operational solutions at the Carlos Slim Health Institute. Before joining the institute, he was the coordinator for knowledge management in public health at the World Health Organization in Geneva, Switzerland.

Novo Nordisk Supports New Global Commitment to Fight Noncommunicable Diseases

Novo Nordisk supports the new framework for action against the largely preventable NCDs.
Press Release

May 30, 2013 /3BL Media/ – This week, the World Health Assembly unanimously adopted a global action plan for the prevention and control of noncommunicable diseases (NCDs) 2013-2020. This is the first time member states of the World Health Organisation agree on a set of global targets for NCDs – leading the way for concerted action against NCDs worldwide, as requested at the UN high-level meeting on NCDs in 2011.

Medtronic Pledges Action in Advance of UN High Level Meeting on Noncommunicable Diseases

The World’s Leading Medical Technology Company Pledges Resources to Improve Healthcare Systems and Access to Therapies in Lower- and Middle-Income Countries
Press Release

(3BL Media / theCSRfeed) Minneapolis, MN - September 15, 2011 - In a continued mission to reduce the global burden of noncommunicable diseases (NCDs) such as cardiovascular disease and diabetes, Medtronic, Inc. (NYSE: MDT) and the Medtronic Foundation today announced a new commitment designed to improve healthcare systems and increase access to life-saving therapies.

Medtronic Foundation Grants Support Action on NCDs

Press Release

 Medtronic Answers United Nations’ Call for “International Commitment” to Non-Communicable Diseases 

Medtronic Global NCD Initiative

Working to help alleviate the global social and economic burden of noncommunicable diseases
Multimedia with summary

Noncommunicable diseases (NCDs), such as diabetes and heart conditions, are surpassing communicable diseases as the world's primary health concern. Eighty percent of people dying from NCDs -- 36 million in 2008 -- live in low- to middle-income countries without sufficient access to care. As a leader in the treatment of chronic diseases, Medtronic is committed to leveraging its people, products and philanthropy to combat this growing global social and economic burden.

Global Health Issues

Podcast series on the Noncommunicable Disease Health Challenge Facing the World
Summary: 

 

Noncommunicable diseases (NCDs) accounted for 63% of global deaths in 2008 -- 36 million people. NCD deaths are projected to increase by 15% globally between 2010 and 2020 – to 44 million. In this podcast series, Medtronic executives discuss how collaboration between the public and private sector is key to alleviating this global issue.
summary

 

Noncommunicable diseases (NCDs) accounted for 63% of global deaths in 2008 -- 36 million people. NCD deaths are projected to increase by 15% globally between 2010 and 2020 – to 44 million. In this podcast series, Medtronic executives discuss how collaboration between the public and private sector is key to alleviating this global issue.
Subscribe to noncommunicable disease